Página 3 - Melhores PET/CT em português de Portugal é traduzido como PET/TAC médicos - TOP-118 médicos

Dr. Saban Sec is a medical oncologist with experience at leading hospitals, including Haseki Training and Research Hospital, Prof. Dr. Cemil Taşcıoğlu City Hospital, and Bahçelievler Medikalpark Hospital. He currently represents specialist physicians in the Turkish Medical Oncology Association. He is also a member of the Istanbul Medical Chamber and the Turkish Medical Oncology Association.

Dr. Sec treats breast, lung, gastrointestinal, prostate, urogenital, head and neck cancers, as well as sarcomas and rare tumors. He has published many peer-reviewed articles on cancer prognosis, treatment outcomes, and survival rates. His research includes studies with large patient groups, such as 138 patients with HER2-positive metastatic gastric cancer. Dr. Sec focuses on prognostic factors and treatment responses in different cancers. He is dedicated to improving cancer care.

Univ.-Prof. Dr. Wolfgang Johannes Köstler is a board-certified specialist for Internal Medicine, Hematology/Oncology, and Intensive Care Medicine who specializes in hematology & internal oncology, intensive care medicine. He is one of the top-rated breast cancer and sarcoma oncologist specialists and has extensive experience in the field and has received degrees from the Medical University of Vienna and the Weizmann Institute of Science. He has also had special training at Memorial Sloan-Kettering Cancer Center and Royal Prince Alfred Hospital.

Dr. Florian Fitzal is a senior physician at Vienna General Hospital and Vienna Medical University. He specializes in breast and abdominal surgery. He is a certified surgeon and holds a Master of Public Health (MBA). Dr. Fitzal leads the Breast Health Center. He also serves as Scientific Director of the Surgical Center of the Breast.

He is an auditor for the European Council of Surgeons. He is also a board member of the Austrian Breast Cancer and Colorectal Cancer Research Group. Dr. Fitzal has published over 143 scientific papers and has an h-index of 24. He has written four books on breast cancer surgery. He is known for his work in breast-conserving, oncoplastic, and reconstructive surgery.

Dr. Sebastian F. Schoppmann is an expert in general and visceral surgery. He has focused on upper gastrointestinal (GI) surgery since 2007. He leads the Gastroesophageal Tumor Unit (CCC-GET) at the Comprehensive Cancer Center Vienna. He is also an Associate Professor of Surgery at the Medical University of Vienna.

Dr. Schoppmann has published over 240 peer-reviewed articles. He serves as a consulting or associate editor for several leading surgical and oncology journals. He is the General Secretary of the Austrian Society of Surgical Oncology. He has also held important leadership roles in surgical oncology organizations. His work has helped advance upper-GI cancer surgery.

Dr. Hossein Taghizadeh is a highly regarded Austrian specialist in internal medicine, hematology, and medical oncology, known for his compassionate approach and commitment to personalized cancer care. With extensive experience in treating solid tumors and blood cancers, he represents a new generation of oncologists who integrate scientific progress with empathy and precision.

He studied medicine at the Medical University of Vienna, graduating in 2016, and began his residency in internal medicine and oncology shortly thereafter. His academic and clinical training at leading Austrian cancer centers equipped him with deep expertise in systemic cancer therapy, hematologic diseases, and palliative medicine.

2010–2016 – Studied medicine at the Medical University of Vienna.

2018 – Began residency in internal medicine and medical oncology, focusing on individualized treatment strategies.

2020s – Specialized in solid tumors, hematologic malignancies, and targeted therapy, contributing to multidisciplinary oncology care.

Today – Practices as an oncologist at Oncodoc and Wiener Privatklinik, providing diagnostics, systemic treatment, and follow-up for patients with gastrointestinal, urogenital, and hematologic cancers.

Dr. Taghizadeh’s clinical interests include gastrointestinal tumors, pancreatic and biliary cancers, genitourinary malignancies, and hematologic neoplasms. He works with advanced diagnostic tools and modern systemic therapies, including chemotherapy, targeted therapy, and immunotherapy.

Known for his calm professionalism, integrity, and patient-centered communication, Dr. Taghizadeh places great emphasis on evidence-based medicine and emotional support throughout the treatment journey. His work reflects a modern, holistic approach to oncology — one that values both medical excellence and the human experience behind every diagnosis.

Dermatologist

Dra. Viola Fox é a Médica Chefe da Clínica de Hematologia, Oncologia e Medicina Paliativa no BKZ Solingen. Esta clínica é um centro de câncer interdisciplinar certificado. A Dra. Fox é uma especialista de destaque em terapia medicamentosa para doenças tumorais na Alemanha e na Europa. Ela tem mais de 15 anos de experiência nesta área.

Ela é membro da Sociedade Alemã de Oncologia e Hemato-oncologia (GDHO), da Associação Alemã de Médicos e da American Association for Cancer Research. A Dra. Fox também é ativa na pesquisa em biologia molecular. Seu trabalho apoia o progresso no tratamento do câncer e nos diagnósticos moleculares.

As suas principais áreas de especialização são a quimioterapia, a imunoterapia, a terapia alvo e a radioterapia. A Dra. Fox é conhecida por seus métodos inovadores e forte compromisso com o cuidado ao paciente. Seus esforços levaram a altas taxas de recuperação e reconhecimento de seus pares.

Education & Expertise

• 1998 to 2004 – Istanbul University, Istanbul Faculty of Medicine
• 2005 to 2009 – Düzce University, Internal Medicine Specialization
• 2009 to 2010 – Beytüşşebap State Hospital, Compulsory Internal Medicine Service
• 2010 to 2013 – Bülent Ecevit University, Medical Oncology Specialization
• 2013 to 2015 – Recep Tayyip Erdoğan University, Medical Oncology Compulsory Service
• 2015 to Present – Associate Professor, Recep Tayyip Erdoğan University
• 2015 to 2021 – Lecturer, Medical Oncology, Sakarya University Faculty of Medicine
• 2020 to Present – Professor, Sakarya University Faculty of Medicine
• 2020 to Present – Ph.D. Student, Inorganic Chemistry, Sakarya University

Experience

• 2008 – Cleveland Clinic, Rheumatology & Gastroenterology Rotation
• 2016 to 2017 – Northeastern University, The Center for Pharmaceutical Biotechnology and Nanomedicine, Boston, U.S.

Professional Memberships

• TTOD (Turkish Society of Medical Oncology)
• ASCO (American Society of Clinical Oncology)
• ESMO (European Society for Medical Oncology)

Associate Professor Dr. Yusuf AÇIKGÖZ
Specialization: Medical Oncology

Education:

• 2004-2011: İnönü University Faculty of Medicine
• 2011-2016: Ankara Numune Training and Research Hospital, Internal Medicine
• 2017-2022: Health Sciences University, Medical Oncology

Professional Experience:

• 2016-2017: Bingöl City Hospital, Internal Medicine
• 2021-2022: Health Sciences University, Medical Oncology
• 2022-2023: Kastamonu Education and Research Hospital, Medical Oncology
• 2023-2024: Ohio State University, Medical Oncology
• 2024-Present: Lokman Hekim University, Medical Oncology, Ankara Hospital

Clinical Trials, Courses, Certifications:

Clinical Trials:

• 2017-2021: Phase III, CheckMate-649 Study (Assistant Investigator)
• 2022-Present: Phase III, Fortitude-101 Study (Assistant Investigator)

Courses:

• 2018: Medicres Basic and Advanced Biostatistics Training Program (ongoing), Istanbul-Vienna
• 2019: Immuno-Oncology Education Course, March 1-2, 2019, Vienna, Central European Cooperative Oncology Group (CECOG)
• 2018: Good Clinical Practice Certification, April 7-8, 2018, Ankara, Health Sciences University
• 2017: Basic Oncology Training Program, November 25-26, 2017, Adana, Clinical Oncology Society
• 2016: Basic Ultrasonography Course (10 hours theoretical + 10 hours practical), September 24-25, 2016, Ankara, Turkish Emergency Medicine Association

Certifications:

• Ongoing: ECFMG Certification
• 2024: CITI Responsible Conduct of Research (The Ohio State University)
• 2024: CITI IACUC-Laboratory Animal Research (The Ohio State University)
• 2024: CITI Human Subjects Protection (The Ohio State University)
• 2024: CITI Good Clinical Practice (The Ohio State University)
• 2023: Occupational English Test (OET)
• 2019: International English Language Testing System (IELTS), Total Score: 6.5, May 26, 2019, Ankara, British Council
• 2017: USMLE Step 2 CK Exam; Score: 244, February 7, 2017
• 2016: USMLE Step 1 Exam; Score: 215, August 25, 2016

Memberships:

• American Society of Clinical Oncology (ASCO) - 2022
• Turkish Society of Medical Oncology - 2020

Education

• 1986-1989, Bursa High School, Bursa, Turkey
• 1989-1995, Istanbul University, Istanbul School of Medicine, Turkey
• 1999-2003, (Residency) Kadir Has University, School of Medicine, Department of Radiation Oncology, Istanbul, Turkey
• 2015, (Associate Professor) Demiroglu Bilim University, Department of Radiation Oncology, Istanbul, Turkey
• 2021, (Professor) Demiroglu Bilim University, Department of Radiation Oncology, Istanbul, Turkey
• 2024, Istanbul Medipol University, Department of Radiation Oncology, Istanbul, Turkey

Experience

• 1995-1999, Şişli Florence Nightingale Hospital, Istanbul, Cardiology Department
• 2003, Gayrettepe Florence Nightingale Hospital, Istanbul, Department of Radiation Oncology
• 2015, (Associate Professor in Radiation Oncology) Demiroglu Bilim University, Department of Radiation Oncology, Istanbul, Turkey
• 2021, (Professor in Radiation Oncology) Demiroglu Bilim University, Department of Radiation Oncology, Istanbul, Turkey
• 2024, Istanbul Medipol University, Department of Radiation Oncology, Istanbul, Turkey

Dr. Liuying leads the Oncology Ward at Jinshazhou Hospital, Guangzhou University of Chinese Medicine. Clinical focus includes hepatocellular carcinoma, cholangiocarcinoma, and lung and colorectal cancers. Dr. Liuying has special expertise in melanoma and melanoma liver metastasis. Interventional skills include MWA, RFA, cryoablation, and radioactive seed implantation for non-vascular, minimally invasive tumor ablation.

Research: participated in two Guangdong Provincial science and technology projects. Contributed to the 2014 Expert Consensus for Thermal Ablation of Primary and Metastatic Lung Tumors. Published in the Chinese Journal of Lung Cancer. Compiled Selected Cases of Microwave Ablation for Lung Tumors and Selected Cases of Microwave Ablation for Liver Tumors.

Appointments: Standing Committee Member, Youth Committee of Intra-Tumor Brachytherapy Medicine, China Medical Education Association. Standing Committee Member, Minimally Invasive Interventional Medicine Professional Committee, Guangdong Primary Medical Association.

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.